The vaccine rollout still has a long way to go

Follow Us Get the newsletter The U.S. was woefully, heartbreakingly slow to respond to the dangers of Covid-19 in the early days of the pandemic. But it has been an early leader in the race to get vaccines to as many of its residents as possible: More than 280 million doses have been administered this year, granting more than 40% of Americans protection from the virus — and the freedom to drop their masks. Still, many say they won't be lining up for shots, and vaccine hesitancy will only prolong the pain. The U.S. can, however, do a lot to promote vaccination both at home and abroad, with the help of science, economics and a few hefty nudges. Get Ready for the Next Wave of Covid Vaccines — Max Nisen I Am Fully Vaccinated. When Do I Need a Booster? — Sam Fazeli Blood Clots Aren't the Only Vaccine Side Effects Worth Studying — Faye Flam Get a Shot, Win $1 Million (or $100,000) — Peter R. Orszag What Else Would You Be Willing to Do For $1 Million? — Noah Smith What Happens When Vaccine Incentives Aren't Enough? — Clara Ferreira Marques The U.S. Must Do More to Vaccinate the World — Bloomberg's editorial board This is the Theme of the Week edition of Bloomberg Opinion Today, a digest of our top commentary published every Sunday.   Like Bloomberg Opinion Today? Subscribe to Bloomberg All Access and get much, much more. You'll receive our unmatched global news coverage and two in-depth daily newsletters, The Bloomberg Open and The Bloomberg Close. Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. Learn more.   You received this message because you are subscribed to Bloomberg's Bloomberg Opinion Today newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022